DE69221369T2 - Verfahren zur Herstellung eines Konzentrates von Blutgerinnungsfaktor XI mit hoher spezifischer Aktivität zur therapeutischen Verwendung - Google Patents
Verfahren zur Herstellung eines Konzentrates von Blutgerinnungsfaktor XI mit hoher spezifischer Aktivität zur therapeutischen VerwendungInfo
- Publication number
- DE69221369T2 DE69221369T2 DE69221369T DE69221369T DE69221369T2 DE 69221369 T2 DE69221369 T2 DE 69221369T2 DE 69221369 T DE69221369 T DE 69221369T DE 69221369 T DE69221369 T DE 69221369T DE 69221369 T2 DE69221369 T2 DE 69221369T2
- Authority
- DE
- Germany
- Prior art keywords
- concentrate
- specific activity
- high specific
- therapeutic use
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6443—Coagulation factor XIa (3.4.21.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21027—Coagulation factor XIa (3.4.21.27)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9105572A FR2676231A1 (fr) | 1991-05-07 | 1991-05-07 | Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation. |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69221369D1 DE69221369D1 (de) | 1997-09-11 |
DE69221369T2 true DE69221369T2 (de) | 1998-03-19 |
Family
ID=9412593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69221369T Expired - Lifetime DE69221369T2 (de) | 1991-05-07 | 1992-04-23 | Verfahren zur Herstellung eines Konzentrates von Blutgerinnungsfaktor XI mit hoher spezifischer Aktivität zur therapeutischen Verwendung |
Country Status (16)
Country | Link |
---|---|
US (1) | US5252217A (de) |
EP (1) | EP0512883B1 (de) |
AT (1) | ATE156360T1 (de) |
AU (1) | AU652043B2 (de) |
BR (1) | BR9201718A (de) |
CA (1) | CA2068069C (de) |
DE (1) | DE69221369T2 (de) |
DK (1) | DK0512883T3 (de) |
EE (1) | EE03017B1 (de) |
ES (1) | ES2107511T3 (de) |
FR (1) | FR2676231A1 (de) |
GR (1) | GR3025134T3 (de) |
IL (1) | IL99567A (de) |
LT (1) | LT3417B (de) |
RU (1) | RU2097047C1 (de) |
UA (1) | UA27733C2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0400976A3 (en) * | 2001-07-20 | 2006-01-30 | Novo Nordisk Healthcare Ag | Pharmaceutical composition comprising factor vii polypeptides and factor xi polypeptides |
US20030040480A1 (en) * | 2001-07-20 | 2003-02-27 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
US20050181978A1 (en) * | 2003-11-20 | 2005-08-18 | Rasmus Rojkjaer | Therapeutic use of factor XI |
AU2004290869A1 (en) * | 2003-11-20 | 2005-06-02 | Novo Nordisk Health Care Ag | Therapeutic use of factor XI |
WO2006128497A1 (en) * | 2005-06-01 | 2006-12-07 | Novo Nordisk A/S | Pharmaceutical formulation of factor xi |
WO2008031020A2 (en) * | 2006-09-08 | 2008-03-13 | Wyeth | Arginine wash in protein purification using affinity chromatography |
US20100062512A1 (en) * | 2007-01-04 | 2010-03-11 | Crucell Holland B.V. | Purification of factor xi |
NZ603603A (en) * | 2008-10-15 | 2014-06-27 | Isis Pharmaceuticals Inc | Modulation of factor 11 expression |
FR2974366B1 (fr) | 2011-04-20 | 2016-06-24 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre de facteur xi |
FR2974301B1 (fr) * | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
IL212911A0 (en) | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
DE102012022233A1 (de) | 2012-11-14 | 2014-05-15 | Instraction Gmbh | Verfahren zur Reinigung eines (Blut)plasmaproteins |
DE102012022234A1 (de) | 2012-11-14 | 2014-05-15 | Instraction Gmbh | Einstufiges Verfahren zur Reinigung von (Blut)Plasmaproteinen wie Albumin aus Gemischen |
FR3032621A1 (fr) | 2015-02-13 | 2016-08-19 | Lab Francais Du Fractionnement | Colle biologique et son utilisation comme medicament |
KR101941974B1 (ko) * | 2016-11-18 | 2019-01-24 | 주식회사 녹십자 | 혈장 단백질 정제시 fxi의 제거방법 |
JP7438135B2 (ja) | 2018-05-09 | 2024-02-26 | アイオーニス ファーマシューティカルズ, インコーポレーテッド | Fxiの発現を低下させるための化合物及び方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859340A (en) * | 1976-03-15 | 1989-08-22 | Cuno, Incorporated | Filter sheet |
US4783262A (en) * | 1987-03-30 | 1988-11-08 | Cuno Incorporated | Separator for cell type filter element |
-
1991
- 1991-05-07 FR FR9105572A patent/FR2676231A1/fr active Granted
- 1991-09-25 IL IL9956791A patent/IL99567A/en not_active IP Right Cessation
-
1992
- 1992-04-23 EP EP92401157A patent/EP0512883B1/de not_active Expired - Lifetime
- 1992-04-23 DK DK92401157.0T patent/DK0512883T3/da active
- 1992-04-23 AT AT92401157T patent/ATE156360T1/de active
- 1992-04-23 DE DE69221369T patent/DE69221369T2/de not_active Expired - Lifetime
- 1992-04-23 ES ES92401157T patent/ES2107511T3/es not_active Expired - Lifetime
- 1992-04-29 AU AU15263/92A patent/AU652043B2/en not_active Expired
- 1992-05-06 RU SU925011788A patent/RU2097047C1/ru active
- 1992-05-06 CA CA002068069A patent/CA2068069C/en not_active Expired - Lifetime
- 1992-05-07 US US07/879,273 patent/US5252217A/en not_active Expired - Lifetime
- 1992-05-07 BR BR929201718A patent/BR9201718A/pt not_active Application Discontinuation
- 1992-12-29 LT LTIP265A patent/LT3417B/lt not_active IP Right Cessation
-
1993
- 1993-05-21 UA UA93002714A patent/UA27733C2/uk unknown
-
1994
- 1994-05-23 EE EE9400003A patent/EE03017B1/xx not_active IP Right Cessation
-
1997
- 1997-10-22 GR GR970402766T patent/GR3025134T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE156360T1 (de) | 1997-08-15 |
DK0512883T3 (da) | 1998-03-16 |
RU2097047C1 (ru) | 1997-11-27 |
AU652043B2 (en) | 1994-08-11 |
IL99567A0 (en) | 1992-08-18 |
UA27733C2 (uk) | 2000-10-16 |
BR9201718A (pt) | 1992-12-29 |
FR2676231A1 (fr) | 1992-11-13 |
GR3025134T3 (en) | 1998-02-27 |
EP0512883A1 (de) | 1992-11-11 |
US5252217A (en) | 1993-10-12 |
ES2107511T3 (es) | 1997-12-01 |
CA2068069C (en) | 2005-03-15 |
IL99567A (en) | 1996-01-19 |
EP0512883B1 (de) | 1997-08-06 |
LTIP265A (en) | 1994-10-25 |
LT3417B (en) | 1995-09-25 |
AU1526392A (en) | 1992-11-12 |
CA2068069A1 (en) | 1992-11-08 |
DE69221369D1 (de) | 1997-09-11 |
EE03017B1 (et) | 1997-08-15 |
FR2676231B1 (de) | 1995-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69221369T2 (de) | Verfahren zur Herstellung eines Konzentrates von Blutgerinnungsfaktor XI mit hoher spezifischer Aktivität zur therapeutischen Verwendung | |
ATE153696T1 (de) | Verfahren und desoxyribonukleinsäure zur herstellung von gewebefaktor-protein | |
ATE63694T1 (de) | Beleuchtungsanordnung fuer ein system zur behandlung eines patienten durch photoaktivierung. | |
DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
IT1219874B (it) | Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche | |
DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
DE68924714T2 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
DE3766619D1 (de) | Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea. | |
ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
DE69313261D1 (de) | Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS | |
ATE107166T1 (de) | Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration. | |
ATE58831T1 (de) | Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea. | |
ATE6639T1 (de) | Ein gereinigtes polypeptid, ein verfahren zu dessen herstellung, dessen anwendung und das enthaltende pharmazeutische praeparat. | |
ATE136776T1 (de) | Verwendung von heptastigmin zur behandlung der zerebralen ictus | |
DE69431320D1 (de) | Verwendung von menschlichem Interferon-d zur Herstellung eines Arzneimittels zur Behandlung von Atemwegserkrankungen in Katzen | |
DE69004051D1 (de) | Verwendung eines Polypeptides mit Gammainterferon-Aktivität zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von primitivem Pleura-Krebs. | |
DE3786442D1 (de) | Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung. | |
ATE124264T1 (de) | Verwendung eines polypeptids mit humaner interleukin-2 aktivität zur herstellung pharmazeutischer zusammensetzungen zur behandlung von pneumothoraxen. | |
ATE188384T1 (de) | Verwendung von kollagen zur behandlung von krankhaften gelenkprozessen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: L'ETABLISSEMENT FRANCAIS DU SANG, LA PLAINE SA, FR |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: CABINET HIRSCH & ASSOCIES, PARIS, FR |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES , FR |
|
R082 | Change of representative |
Ref document number: 512883 Country of ref document: EP Representative=s name: MEHLER ACHLER PATENTANWAELTE, 65185 WIESBADEN, DE |
|
R071 | Expiry of right |
Ref document number: 512883 Country of ref document: EP |